nodes	percent_of_prediction	percent_of_DWPC	metapath
Etravirine—CYP3A4—Thiotepa—sarcoma	0.142	0.202	CbGbCtD
Etravirine—ABCB1—Dactinomycin—sarcoma	0.114	0.162	CbGbCtD
Etravirine—ABCB1—Mitoxantrone—sarcoma	0.102	0.145	CbGbCtD
Etravirine—ABCB1—Vincristine—sarcoma	0.0702	0.0996	CbGbCtD
Etravirine—ABCB1—Etoposide—sarcoma	0.0644	0.0913	CbGbCtD
Etravirine—CYP3A4—Mitoxantrone—sarcoma	0.0611	0.0868	CbGbCtD
Etravirine—ABCB1—Doxorubicin—sarcoma	0.0439	0.0623	CbGbCtD
Etravirine—CYP3A4—Vincristine—sarcoma	0.0421	0.0597	CbGbCtD
Etravirine—CYP3A4—Etoposide—sarcoma	0.0386	0.0547	CbGbCtD
Etravirine—CYP3A4—Doxorubicin—sarcoma	0.0263	0.0373	CbGbCtD
Etravirine—Pain—Dactinomycin—sarcoma	0.000765	0.00259	CcSEcCtD
Etravirine—Thrombocytopenia—Mitoxantrone—sarcoma	0.000762	0.00258	CcSEcCtD
Etravirine—Anorexia—Vincristine—sarcoma	0.000762	0.00258	CcSEcCtD
Etravirine—Hepatic failure—Doxorubicin—sarcoma	0.000761	0.00258	CcSEcCtD
Etravirine—Skin disorder—Mitoxantrone—sarcoma	0.000756	0.00256	CcSEcCtD
Etravirine—Hyperhidrosis—Mitoxantrone—sarcoma	0.000753	0.00255	CcSEcCtD
Etravirine—Feeling abnormal—Thiotepa—sarcoma	0.000743	0.00252	CcSEcCtD
Etravirine—Anorexia—Mitoxantrone—sarcoma	0.000742	0.00251	CcSEcCtD
Etravirine—Renal failure acute—Doxorubicin—sarcoma	0.00074	0.00251	CcSEcCtD
Etravirine—Feeling abnormal—Dactinomycin—sarcoma	0.000737	0.0025	CcSEcCtD
Etravirine—Gastrointestinal pain—Thiotepa—sarcoma	0.000737	0.0025	CcSEcCtD
Etravirine—Ill-defined disorder—Etoposide—sarcoma	0.000736	0.00249	CcSEcCtD
Etravirine—Anaemia—Etoposide—sarcoma	0.000733	0.00248	CcSEcCtD
Etravirine—Gastrointestinal pain—Dactinomycin—sarcoma	0.000732	0.00248	CcSEcCtD
Etravirine—Insomnia—Vincristine—sarcoma	0.000723	0.00245	CcSEcCtD
Etravirine—Paraesthesia—Vincristine—sarcoma	0.000718	0.00243	CcSEcCtD
Etravirine—Malaise—Etoposide—sarcoma	0.000716	0.00242	CcSEcCtD
Etravirine—Dermatitis bullous—Doxorubicin—sarcoma	0.000715	0.00242	CcSEcCtD
Etravirine—Vertigo—Etoposide—sarcoma	0.000713	0.00242	CcSEcCtD
Etravirine—Abdominal pain—Thiotepa—sarcoma	0.000713	0.00241	CcSEcCtD
Etravirine—Body temperature increased—Thiotepa—sarcoma	0.000713	0.00241	CcSEcCtD
Etravirine—Abdominal pain—Dactinomycin—sarcoma	0.000707	0.0024	CcSEcCtD
Etravirine—Body temperature increased—Dactinomycin—sarcoma	0.000707	0.0024	CcSEcCtD
Etravirine—Paraesthesia—Mitoxantrone—sarcoma	0.000699	0.00237	CcSEcCtD
Etravirine—Loss of consciousness—Etoposide—sarcoma	0.000697	0.00236	CcSEcCtD
Etravirine—Decreased appetite—Vincristine—sarcoma	0.000695	0.00235	CcSEcCtD
Etravirine—Somnolence—Mitoxantrone—sarcoma	0.000692	0.00235	CcSEcCtD
Etravirine—Gastrointestinal disorder—Vincristine—sarcoma	0.00069	0.00234	CcSEcCtD
Etravirine—Fatigue—Vincristine—sarcoma	0.000689	0.00234	CcSEcCtD
Etravirine—Convulsion—Etoposide—sarcoma	0.000688	0.00233	CcSEcCtD
Etravirine—Hypertension—Etoposide—sarcoma	0.000685	0.00232	CcSEcCtD
Etravirine—Pain—Vincristine—sarcoma	0.000684	0.00232	CcSEcCtD
Etravirine—Constipation—Vincristine—sarcoma	0.000684	0.00232	CcSEcCtD
Etravirine—Dry skin—Epirubicin—sarcoma	0.000677	0.00229	CcSEcCtD
Etravirine—Decreased appetite—Mitoxantrone—sarcoma	0.000677	0.00229	CcSEcCtD
Etravirine—Fatigue—Mitoxantrone—sarcoma	0.000671	0.00227	CcSEcCtD
Etravirine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.000671	0.00227	CcSEcCtD
Etravirine—Discomfort—Etoposide—sarcoma	0.000668	0.00226	CcSEcCtD
Etravirine—Breast disorder—Epirubicin—sarcoma	0.000668	0.00226	CcSEcCtD
Etravirine—Pain—Mitoxantrone—sarcoma	0.000666	0.00226	CcSEcCtD
Etravirine—Constipation—Mitoxantrone—sarcoma	0.000666	0.00226	CcSEcCtD
Etravirine—Toxic epidermal necrolysis—Epirubicin—sarcoma	0.000665	0.00225	CcSEcCtD
Etravirine—Hypersensitivity—Thiotepa—sarcoma	0.000664	0.00225	CcSEcCtD
Etravirine—Hypersensitivity—Dactinomycin—sarcoma	0.000659	0.00223	CcSEcCtD
Etravirine—Gastrointestinal pain—Vincristine—sarcoma	0.000654	0.00221	CcSEcCtD
Etravirine—Gastritis—Epirubicin—sarcoma	0.000654	0.00221	CcSEcCtD
Etravirine—Confusional state—Etoposide—sarcoma	0.000653	0.00221	CcSEcCtD
Etravirine—Asthenia—Thiotepa—sarcoma	0.000647	0.00219	CcSEcCtD
Etravirine—Infection—Etoposide—sarcoma	0.000643	0.00218	CcSEcCtD
Etravirine—Abdominal distension—Epirubicin—sarcoma	0.000643	0.00218	CcSEcCtD
Etravirine—Asthenia—Dactinomycin—sarcoma	0.000642	0.00218	CcSEcCtD
Etravirine—Feeling abnormal—Mitoxantrone—sarcoma	0.000642	0.00217	CcSEcCtD
Etravirine—Gastrointestinal pain—Mitoxantrone—sarcoma	0.000637	0.00216	CcSEcCtD
Etravirine—Thrombocytopenia—Etoposide—sarcoma	0.000634	0.00215	CcSEcCtD
Etravirine—Eosinophilia—Epirubicin—sarcoma	0.000632	0.00214	CcSEcCtD
Etravirine—Abdominal pain—Vincristine—sarcoma	0.000632	0.00214	CcSEcCtD
Etravirine—Body temperature increased—Vincristine—sarcoma	0.000632	0.00214	CcSEcCtD
Etravirine—Skin disorder—Etoposide—sarcoma	0.000629	0.00213	CcSEcCtD
Etravirine—Dry skin—Doxorubicin—sarcoma	0.000626	0.00212	CcSEcCtD
Etravirine—Hyperhidrosis—Etoposide—sarcoma	0.000626	0.00212	CcSEcCtD
Etravirine—Pancreatitis—Epirubicin—sarcoma	0.000626	0.00212	CcSEcCtD
Etravirine—Angina pectoris—Epirubicin—sarcoma	0.000622	0.00211	CcSEcCtD
Etravirine—Breast disorder—Doxorubicin—sarcoma	0.000618	0.00209	CcSEcCtD
Etravirine—Anorexia—Etoposide—sarcoma	0.000617	0.00209	CcSEcCtD
Etravirine—Diarrhoea—Thiotepa—sarcoma	0.000617	0.00209	CcSEcCtD
Etravirine—Abdominal pain—Mitoxantrone—sarcoma	0.000616	0.00209	CcSEcCtD
Etravirine—Body temperature increased—Mitoxantrone—sarcoma	0.000616	0.00209	CcSEcCtD
Etravirine—Toxic epidermal necrolysis—Doxorubicin—sarcoma	0.000615	0.00209	CcSEcCtD
Etravirine—Diarrhoea—Dactinomycin—sarcoma	0.000612	0.00207	CcSEcCtD
Etravirine—Gastritis—Doxorubicin—sarcoma	0.000605	0.00205	CcSEcCtD
Etravirine—Dizziness—Thiotepa—sarcoma	0.000596	0.00202	CcSEcCtD
Etravirine—Abdominal distension—Doxorubicin—sarcoma	0.000595	0.00201	CcSEcCtD
Etravirine—Hypersensitivity—Vincristine—sarcoma	0.000589	0.002	CcSEcCtD
Etravirine—Eosinophilia—Doxorubicin—sarcoma	0.000585	0.00198	CcSEcCtD
Etravirine—Paraesthesia—Etoposide—sarcoma	0.000582	0.00197	CcSEcCtD
Etravirine—Pancreatitis—Doxorubicin—sarcoma	0.000579	0.00196	CcSEcCtD
Etravirine—Hyperglycaemia—Epirubicin—sarcoma	0.000576	0.00195	CcSEcCtD
Etravirine—Somnolence—Etoposide—sarcoma	0.000576	0.00195	CcSEcCtD
Etravirine—Angina pectoris—Doxorubicin—sarcoma	0.000575	0.00195	CcSEcCtD
Etravirine—Hypersensitivity—Mitoxantrone—sarcoma	0.000574	0.00194	CcSEcCtD
Etravirine—Asthenia—Vincristine—sarcoma	0.000574	0.00194	CcSEcCtD
Etravirine—Vomiting—Thiotepa—sarcoma	0.000573	0.00194	CcSEcCtD
Etravirine—Vomiting—Dactinomycin—sarcoma	0.000569	0.00193	CcSEcCtD
Etravirine—Rash—Thiotepa—sarcoma	0.000568	0.00193	CcSEcCtD
Etravirine—Dermatitis—Thiotepa—sarcoma	0.000568	0.00192	CcSEcCtD
Etravirine—Headache—Thiotepa—sarcoma	0.000565	0.00191	CcSEcCtD
Etravirine—Stevens-Johnson syndrome—Epirubicin—sarcoma	0.000564	0.00191	CcSEcCtD
Etravirine—Rash—Dactinomycin—sarcoma	0.000564	0.00191	CcSEcCtD
Etravirine—Decreased appetite—Etoposide—sarcoma	0.000563	0.00191	CcSEcCtD
Etravirine—Renal failure—Epirubicin—sarcoma	0.00056	0.0019	CcSEcCtD
Etravirine—Gastrointestinal disorder—Etoposide—sarcoma	0.000559	0.00189	CcSEcCtD
Etravirine—Asthenia—Mitoxantrone—sarcoma	0.000559	0.00189	CcSEcCtD
Etravirine—Fatigue—Etoposide—sarcoma	0.000558	0.00189	CcSEcCtD
Etravirine—Neuropathy peripheral—Epirubicin—sarcoma	0.000558	0.00189	CcSEcCtD
Etravirine—Stomatitis—Epirubicin—sarcoma	0.000555	0.00188	CcSEcCtD
Etravirine—Pain—Etoposide—sarcoma	0.000554	0.00188	CcSEcCtD
Etravirine—Constipation—Etoposide—sarcoma	0.000554	0.00188	CcSEcCtD
Etravirine—Conjunctivitis—Epirubicin—sarcoma	0.000553	0.00187	CcSEcCtD
Etravirine—Diarrhoea—Vincristine—sarcoma	0.000547	0.00185	CcSEcCtD
Etravirine—Hepatobiliary disease—Epirubicin—sarcoma	0.000538	0.00182	CcSEcCtD
Etravirine—Nausea—Thiotepa—sarcoma	0.000536	0.00181	CcSEcCtD
Etravirine—Feeling abnormal—Etoposide—sarcoma	0.000534	0.00181	CcSEcCtD
Etravirine—Hyperglycaemia—Doxorubicin—sarcoma	0.000533	0.00181	CcSEcCtD
Etravirine—Diarrhoea—Mitoxantrone—sarcoma	0.000533	0.0018	CcSEcCtD
Etravirine—Nausea—Dactinomycin—sarcoma	0.000532	0.0018	CcSEcCtD
Etravirine—Gastrointestinal pain—Etoposide—sarcoma	0.00053	0.00179	CcSEcCtD
Etravirine—Dizziness—Vincristine—sarcoma	0.000529	0.00179	CcSEcCtD
Etravirine—Stevens-Johnson syndrome—Doxorubicin—sarcoma	0.000522	0.00177	CcSEcCtD
Etravirine—Renal failure—Doxorubicin—sarcoma	0.000518	0.00175	CcSEcCtD
Etravirine—Neuropathy peripheral—Doxorubicin—sarcoma	0.000516	0.00175	CcSEcCtD
Etravirine—Stomatitis—Doxorubicin—sarcoma	0.000513	0.00174	CcSEcCtD
Etravirine—Abdominal pain—Etoposide—sarcoma	0.000512	0.00173	CcSEcCtD
Etravirine—Body temperature increased—Etoposide—sarcoma	0.000512	0.00173	CcSEcCtD
Etravirine—Conjunctivitis—Doxorubicin—sarcoma	0.000512	0.00173	CcSEcCtD
Etravirine—Hepatitis—Epirubicin—sarcoma	0.000511	0.00173	CcSEcCtD
Etravirine—Hypoaesthesia—Epirubicin—sarcoma	0.000508	0.00172	CcSEcCtD
Etravirine—Vomiting—Vincristine—sarcoma	0.000508	0.00172	CcSEcCtD
Etravirine—Urinary tract disorder—Epirubicin—sarcoma	0.000505	0.00171	CcSEcCtD
Etravirine—Rash—Vincristine—sarcoma	0.000504	0.00171	CcSEcCtD
Etravirine—Dermatitis—Vincristine—sarcoma	0.000504	0.00171	CcSEcCtD
Etravirine—Connective tissue disorder—Epirubicin—sarcoma	0.000502	0.0017	CcSEcCtD
Etravirine—Urethral disorder—Epirubicin—sarcoma	0.000501	0.0017	CcSEcCtD
Etravirine—Headache—Vincristine—sarcoma	0.000501	0.0017	CcSEcCtD
Etravirine—Hepatobiliary disease—Doxorubicin—sarcoma	0.000498	0.00169	CcSEcCtD
Etravirine—Vomiting—Mitoxantrone—sarcoma	0.000495	0.00168	CcSEcCtD
Etravirine—Rash—Mitoxantrone—sarcoma	0.000491	0.00166	CcSEcCtD
Etravirine—Dermatitis—Mitoxantrone—sarcoma	0.00049	0.00166	CcSEcCtD
Etravirine—Headache—Mitoxantrone—sarcoma	0.000488	0.00165	CcSEcCtD
Etravirine—Erythema multiforme—Epirubicin—sarcoma	0.000483	0.00164	CcSEcCtD
Etravirine—Eye disorder—Epirubicin—sarcoma	0.000478	0.00162	CcSEcCtD
Etravirine—Hypersensitivity—Etoposide—sarcoma	0.000477	0.00162	CcSEcCtD
Etravirine—Nausea—Vincristine—sarcoma	0.000475	0.00161	CcSEcCtD
Etravirine—Cardiac disorder—Epirubicin—sarcoma	0.000474	0.00161	CcSEcCtD
Etravirine—Hepatitis—Doxorubicin—sarcoma	0.000473	0.0016	CcSEcCtD
Etravirine—Hypoaesthesia—Doxorubicin—sarcoma	0.00047	0.00159	CcSEcCtD
Etravirine—Urinary tract disorder—Doxorubicin—sarcoma	0.000467	0.00158	CcSEcCtD
Etravirine—Asthenia—Etoposide—sarcoma	0.000465	0.00157	CcSEcCtD
Etravirine—Connective tissue disorder—Doxorubicin—sarcoma	0.000465	0.00157	CcSEcCtD
Etravirine—Angiopathy—Epirubicin—sarcoma	0.000464	0.00157	CcSEcCtD
Etravirine—Urethral disorder—Doxorubicin—sarcoma	0.000463	0.00157	CcSEcCtD
Etravirine—Nausea—Mitoxantrone—sarcoma	0.000462	0.00157	CcSEcCtD
Etravirine—Immune system disorder—Epirubicin—sarcoma	0.000462	0.00156	CcSEcCtD
Etravirine—Mediastinal disorder—Epirubicin—sarcoma	0.000461	0.00156	CcSEcCtD
Etravirine—Mental disorder—Epirubicin—sarcoma	0.000448	0.00152	CcSEcCtD
Etravirine—Erythema multiforme—Doxorubicin—sarcoma	0.000447	0.00151	CcSEcCtD
Etravirine—Malnutrition—Epirubicin—sarcoma	0.000445	0.00151	CcSEcCtD
Etravirine—Diarrhoea—Etoposide—sarcoma	0.000443	0.0015	CcSEcCtD
Etravirine—Eye disorder—Doxorubicin—sarcoma	0.000442	0.0015	CcSEcCtD
Etravirine—Cardiac disorder—Doxorubicin—sarcoma	0.000439	0.00149	CcSEcCtD
Etravirine—Flatulence—Epirubicin—sarcoma	0.000438	0.00149	CcSEcCtD
Etravirine—Tension—Epirubicin—sarcoma	0.000437	0.00148	CcSEcCtD
Etravirine—Nervousness—Epirubicin—sarcoma	0.000432	0.00146	CcSEcCtD
Etravirine—Angiopathy—Doxorubicin—sarcoma	0.000429	0.00145	CcSEcCtD
Etravirine—Dizziness—Etoposide—sarcoma	0.000428	0.00145	CcSEcCtD
Etravirine—Immune system disorder—Doxorubicin—sarcoma	0.000427	0.00145	CcSEcCtD
Etravirine—Mediastinal disorder—Doxorubicin—sarcoma	0.000426	0.00144	CcSEcCtD
Etravirine—Vision blurred—Epirubicin—sarcoma	0.000419	0.00142	CcSEcCtD
Etravirine—Mental disorder—Doxorubicin—sarcoma	0.000414	0.0014	CcSEcCtD
Etravirine—Ill-defined disorder—Epirubicin—sarcoma	0.000413	0.0014	CcSEcCtD
Etravirine—Vomiting—Etoposide—sarcoma	0.000412	0.0014	CcSEcCtD
Etravirine—Malnutrition—Doxorubicin—sarcoma	0.000412	0.00139	CcSEcCtD
Etravirine—Anaemia—Epirubicin—sarcoma	0.000411	0.00139	CcSEcCtD
Etravirine—Rash—Etoposide—sarcoma	0.000408	0.00138	CcSEcCtD
Etravirine—Dermatitis—Etoposide—sarcoma	0.000408	0.00138	CcSEcCtD
Etravirine—Headache—Etoposide—sarcoma	0.000406	0.00137	CcSEcCtD
Etravirine—Flatulence—Doxorubicin—sarcoma	0.000406	0.00137	CcSEcCtD
Etravirine—Tension—Doxorubicin—sarcoma	0.000404	0.00137	CcSEcCtD
Etravirine—Malaise—Epirubicin—sarcoma	0.000401	0.00136	CcSEcCtD
Etravirine—Nervousness—Doxorubicin—sarcoma	0.0004	0.00135	CcSEcCtD
Etravirine—Vertigo—Epirubicin—sarcoma	0.0004	0.00135	CcSEcCtD
Etravirine—Syncope—Epirubicin—sarcoma	0.000399	0.00135	CcSEcCtD
Etravirine—Loss of consciousness—Epirubicin—sarcoma	0.000391	0.00132	CcSEcCtD
Etravirine—Vision blurred—Doxorubicin—sarcoma	0.000388	0.00131	CcSEcCtD
Etravirine—Convulsion—Epirubicin—sarcoma	0.000385	0.00131	CcSEcCtD
Etravirine—Nausea—Etoposide—sarcoma	0.000385	0.0013	CcSEcCtD
Etravirine—Hypertension—Epirubicin—sarcoma	0.000384	0.0013	CcSEcCtD
Etravirine—Ill-defined disorder—Doxorubicin—sarcoma	0.000382	0.00129	CcSEcCtD
Etravirine—Anaemia—Doxorubicin—sarcoma	0.00038	0.00129	CcSEcCtD
Etravirine—Anxiety—Epirubicin—sarcoma	0.000377	0.00128	CcSEcCtD
Etravirine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000376	0.00127	CcSEcCtD
Etravirine—Discomfort—Epirubicin—sarcoma	0.000374	0.00127	CcSEcCtD
Etravirine—Malaise—Doxorubicin—sarcoma	0.000371	0.00126	CcSEcCtD
Etravirine—Dry mouth—Epirubicin—sarcoma	0.00037	0.00125	CcSEcCtD
Etravirine—Vertigo—Doxorubicin—sarcoma	0.00037	0.00125	CcSEcCtD
Etravirine—Syncope—Doxorubicin—sarcoma	0.000369	0.00125	CcSEcCtD
Etravirine—Confusional state—Epirubicin—sarcoma	0.000366	0.00124	CcSEcCtD
Etravirine—Loss of consciousness—Doxorubicin—sarcoma	0.000362	0.00123	CcSEcCtD
Etravirine—Infection—Epirubicin—sarcoma	0.000361	0.00122	CcSEcCtD
Etravirine—Shock—Epirubicin—sarcoma	0.000357	0.00121	CcSEcCtD
Etravirine—Convulsion—Doxorubicin—sarcoma	0.000357	0.00121	CcSEcCtD
Etravirine—Nervous system disorder—Epirubicin—sarcoma	0.000356	0.00121	CcSEcCtD
Etravirine—Thrombocytopenia—Epirubicin—sarcoma	0.000355	0.0012	CcSEcCtD
Etravirine—Hypertension—Doxorubicin—sarcoma	0.000355	0.0012	CcSEcCtD
Etravirine—Skin disorder—Epirubicin—sarcoma	0.000353	0.00119	CcSEcCtD
Etravirine—Hyperhidrosis—Epirubicin—sarcoma	0.000351	0.00119	CcSEcCtD
Etravirine—Anxiety—Doxorubicin—sarcoma	0.000349	0.00118	CcSEcCtD
Etravirine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000348	0.00118	CcSEcCtD
Etravirine—Discomfort—Doxorubicin—sarcoma	0.000346	0.00117	CcSEcCtD
Etravirine—Anorexia—Epirubicin—sarcoma	0.000346	0.00117	CcSEcCtD
Etravirine—Dry mouth—Doxorubicin—sarcoma	0.000343	0.00116	CcSEcCtD
Etravirine—Confusional state—Doxorubicin—sarcoma	0.000339	0.00115	CcSEcCtD
Etravirine—Infection—Doxorubicin—sarcoma	0.000334	0.00113	CcSEcCtD
Etravirine—Shock—Doxorubicin—sarcoma	0.00033	0.00112	CcSEcCtD
Etravirine—Nervous system disorder—Doxorubicin—sarcoma	0.000329	0.00112	CcSEcCtD
Etravirine—Thrombocytopenia—Doxorubicin—sarcoma	0.000329	0.00111	CcSEcCtD
Etravirine—Insomnia—Epirubicin—sarcoma	0.000328	0.00111	CcSEcCtD
Etravirine—Skin disorder—Doxorubicin—sarcoma	0.000326	0.00111	CcSEcCtD
Etravirine—Paraesthesia—Epirubicin—sarcoma	0.000326	0.0011	CcSEcCtD
Etravirine—Hyperhidrosis—Doxorubicin—sarcoma	0.000325	0.0011	CcSEcCtD
Etravirine—Somnolence—Epirubicin—sarcoma	0.000323	0.00109	CcSEcCtD
Etravirine—Anorexia—Doxorubicin—sarcoma	0.00032	0.00108	CcSEcCtD
Etravirine—Decreased appetite—Epirubicin—sarcoma	0.000316	0.00107	CcSEcCtD
Etravirine—Gastrointestinal disorder—Epirubicin—sarcoma	0.000313	0.00106	CcSEcCtD
Etravirine—Fatigue—Epirubicin—sarcoma	0.000313	0.00106	CcSEcCtD
Etravirine—Constipation—Epirubicin—sarcoma	0.00031	0.00105	CcSEcCtD
Etravirine—Pain—Epirubicin—sarcoma	0.00031	0.00105	CcSEcCtD
Etravirine—Insomnia—Doxorubicin—sarcoma	0.000304	0.00103	CcSEcCtD
Etravirine—Paraesthesia—Doxorubicin—sarcoma	0.000302	0.00102	CcSEcCtD
Etravirine—Feeling abnormal—Epirubicin—sarcoma	0.000299	0.00101	CcSEcCtD
Etravirine—Somnolence—Doxorubicin—sarcoma	0.000299	0.00101	CcSEcCtD
Etravirine—Gastrointestinal pain—Epirubicin—sarcoma	0.000297	0.00101	CcSEcCtD
Etravirine—Decreased appetite—Doxorubicin—sarcoma	0.000292	0.000989	CcSEcCtD
Etravirine—Gastrointestinal disorder—Doxorubicin—sarcoma	0.00029	0.000983	CcSEcCtD
Etravirine—Fatigue—Doxorubicin—sarcoma	0.00029	0.000981	CcSEcCtD
Etravirine—Pain—Doxorubicin—sarcoma	0.000287	0.000973	CcSEcCtD
Etravirine—Constipation—Doxorubicin—sarcoma	0.000287	0.000973	CcSEcCtD
Etravirine—Body temperature increased—Epirubicin—sarcoma	0.000287	0.000972	CcSEcCtD
Etravirine—Abdominal pain—Epirubicin—sarcoma	0.000287	0.000972	CcSEcCtD
Etravirine—Feeling abnormal—Doxorubicin—sarcoma	0.000277	0.000938	CcSEcCtD
Etravirine—Gastrointestinal pain—Doxorubicin—sarcoma	0.000275	0.000931	CcSEcCtD
Etravirine—Hypersensitivity—Epirubicin—sarcoma	0.000267	0.000906	CcSEcCtD
Etravirine—Abdominal pain—Doxorubicin—sarcoma	0.000266	0.0009	CcSEcCtD
Etravirine—Body temperature increased—Doxorubicin—sarcoma	0.000266	0.0009	CcSEcCtD
Etravirine—Asthenia—Epirubicin—sarcoma	0.00026	0.000882	CcSEcCtD
Etravirine—Diarrhoea—Epirubicin—sarcoma	0.000248	0.000842	CcSEcCtD
Etravirine—Hypersensitivity—Doxorubicin—sarcoma	0.000247	0.000838	CcSEcCtD
Etravirine—Asthenia—Doxorubicin—sarcoma	0.000241	0.000817	CcSEcCtD
Etravirine—Dizziness—Epirubicin—sarcoma	0.00024	0.000813	CcSEcCtD
Etravirine—Vomiting—Epirubicin—sarcoma	0.000231	0.000782	CcSEcCtD
Etravirine—Diarrhoea—Doxorubicin—sarcoma	0.00023	0.000779	CcSEcCtD
Etravirine—Rash—Epirubicin—sarcoma	0.000229	0.000776	CcSEcCtD
Etravirine—Dermatitis—Epirubicin—sarcoma	0.000229	0.000775	CcSEcCtD
Etravirine—Headache—Epirubicin—sarcoma	0.000227	0.000771	CcSEcCtD
Etravirine—Dizziness—Doxorubicin—sarcoma	0.000222	0.000753	CcSEcCtD
Etravirine—Nausea—Epirubicin—sarcoma	0.000216	0.000731	CcSEcCtD
Etravirine—Vomiting—Doxorubicin—sarcoma	0.000214	0.000724	CcSEcCtD
Etravirine—Rash—Doxorubicin—sarcoma	0.000212	0.000718	CcSEcCtD
Etravirine—Dermatitis—Doxorubicin—sarcoma	0.000212	0.000717	CcSEcCtD
Etravirine—Headache—Doxorubicin—sarcoma	0.00021	0.000713	CcSEcCtD
Etravirine—Nausea—Doxorubicin—sarcoma	0.0002	0.000676	CcSEcCtD
